Drug interactions
Diazoxide + Linagliptin-metformin
Severity: Major
Diazoxide and Linagliptin-metformin: major interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Diazoxide opens pancreatic potassium channels, suppressing insulin secretion and causing hyperglycemia. This directly opposes the effect of antidiabetic drugs and can cause marked loss of glycemic control.
What this interaction means in plain words
Diazoxide and Linagliptin-metformin can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Diazoxide belongs to Miscellaneous; Linagliptin-metformin belongs to Endocrine.
Why it happens
Diazoxide activates KATP channels in beta cells, inhibiting insulin release and raising blood glucose.
What to do
Monitor blood glucose closely and be prepared to increase antidiabetic therapy; reassess doses when diazoxide is stopped.
What to ask your pharmacist
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Diazoxide and Linagliptin-metformin, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 14 days on the web. No card needed.
Other interactions of Linagliptin-metformin
Other interactions of Diazoxide
Frequently asked questions
Can I take Diazoxide with Linagliptin-metformin?
MediHelp rates the interaction as major. Diazoxide and Linagliptin-metformin can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Diazoxide opens pancreatic potassium channels, suppressing insulin secretion and causing hyperglycemia. This directly opposes the effect of antidiabetic drugs and can cause marked loss of glycemic control.
How serious is the interaction between Diazoxide and Linagliptin-metformin?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood glucose closely and be prepared to increase antidiabetic therapy; reassess doses when diazoxide is stopped.
What other medicines interact with Linagliptin-metformin?
MediHelp also lists interactions of Linagliptin-metformin with, for example, Apalutamide, Carbamazepine, Contrast media. The full list is on the Linagliptin-metformin page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
